LATEST

PSA screening: What do you tell primary care docs?We asked several urologists about whether they advocate for PSA screening to primary care physicians in their area.
Cisplatin nanoparticles appear efficacious for treating NMIBCThe use of intravesical cisplatin nanoparticles reduces cancer cell proliferation while limiting drug absorption beyond the bladder barrier, according to early findings.
Bladder Ca subtypes ID’d, may yield personalized therapiesResearchers from The Cancer Genome Atlas Research Network have outlined five distinct expression subtypes of muscle-invasive bladder cancer, each of which may be targetable by different treatments.
Sacral neuromodulation, botulinum show equal efficacyIn patients with refractory urgency urinary incontinence (UUI), sacral neuromodulation (InterStim) and onabotulinumtoxinA (Botox) produce similar reductions in mean daily UUI episodes, according to 24-month follow-up data on patients treated in a randomized trial.
Urology-specific APMs to encompass PCa, BPH, OAB“The APMs being designed by LUGPA allow for participation by all urologists regardless of their practice setting or affiliation,” explains Alec Koo, MD.
How care process models can help your practice“Care process models… represent a way to decrease variation and waste, and thereby they lead to improved outcomes and significant cost reductions,” says Jay T. Bishoff, MD.
Prevent burnout by restoring professional fulfillment“The answer is to remove the barriers and frustrations that are causing burnout so that physicians can focus on their role as care providers,” advises Paul DeChant, MD, MBA.
PCa active surveillance trends revealed in ‘real-world’ studyNearly three-fourths of men with very low-risk prostate cancer underwent active surveillance as a primary therapy, according to a study presented at the LUGPA annual meeting in Chicago.
LUGPA advocacy targets self-referral laws, USPSTF reformIn his health policy briefing, Deepak A. Kapoor, MD, discusses LUGPA’s comments to CMS regarding MACRA and the 2018 Medicare physician fee schedule.
LUGPA puts resources behind key policy initiatives, future leadersThe association and its member groups are “leading the way” in developing urology-specific measures that can be used for MIPS quality reporting, says LUGPA President Neal D. Shore, MD.

Poll